Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA

Recruiting now · Not applicable

Conditions studied: Aortic Arch Aneurysm, Aortic Arch Dissection, Chronic Aortic Dissection, Acute Aortic Dissection

In brief

The goal of this clinical trial is to learn if the Arcevo LSA stent graft can safely and effectively treat patients that have an acute or chronic aortic dissection and/or aneurysm that involves the aortic arch and the descending thoracic aorta, with or without the involvement of the ascending aorta.

Key facts

Study ID
NCT07089576
Run by
Artivion Inc.
People needed
132
Starts
2025-11-04
Expected to finish
2032-07-01
Last updated by the study team
2026-07-10

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.